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Illness and Demographic Correlates of Chronic Pain Among a Community-
Based Sample of People with Multiple Sclerosis 
 
Objective: To investigate the prevalence, nature, and correlates of pain among a 
community-based sample of people with multiple sclerosis (MS). 
Design: Cross-sectional survey and structured pain interview. 
Setting: Community. 
Participants: Two hundred and nineteen people with MS recruited via systematic 
sampling from a randomly ordered MS society membership database. 
Intervention: Not applicable. 
Main Outcome Measures: Pain presence or absence, pain intensity (numerical rating 
scales), pain quality (McGill Pain Questionnaire), pain location(s) and extent (pain 
drawing), pain duration and frequency, provoking and relieving pain factors, and pain 
management techniques. 
Results: Pain was found to be common with some 67.1% of the sample reporting pain 
during the two weeks preceding the study. Comprehensive pain assessment revealed 
that a substantial subset of these individuals experience chronic pain conditions 
characterised by moderate-to-severe pain intensity. Among those with pain, three-
quarters reported pain in 3 or more locations, with participants reporting an average of 
4.0 (SD = 1.8) distinct pain sites. Women and individuals with more severe MS-
related disability were significantly more likely to report both the presence of pain and 
greater pain intensity. In contrast, being in a married/defacto relationship and longer 
time since MS diagnosis were significantly associated with lower pain intensity. 
Conclusion: Given the high prevalence and nature of pain experienced by people 
with MS, health care providers need to approach pain with a similar priority given to 
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other MS-related problems such as mobility and functional independence. Women 
and individuals with more severe MS-related disability appear to be at particular risk 
for significant pain problems and therefore these groups warrant particular attention, 
such that routine clinical assessment should trigger routine pain assessment.  
 
Key Words: Multiple sclerosis; Pain; Prevalence. 
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Illness and Demographic Correlates of Chronic Pain Among a Community-
Based Sample of People with Multiple Sclerosis 
 
Although an extensive literature exists on the nature of and treatments for 
chronic pain as a primary condition, little is known about the impact of chronic pain 
as a secondary problem in people who already have a disability such as multiple 
sclerosis (MS).1, 2 Despite the paucity of literature on MS-related pain, it is evident 
that pain is a common problem over the course of the disease. Estimates of the 
prevalence of pain in MS range from as low as 29%3, to as high as 90%4, with recent 
studies indicating that approximately two-thirds experience pain.5–7 Thus, it is clear 
that pain affects a considerable proportion of the MS population. Beyond this 
consistent finding however, the extant literature is extremely limited in size, scope 
and methodology. 
 
Thus far, evidence concerning the relationship between MS-related pain and 
illness and demographic variables is inconclusive and contradictory. In several cross-
sectional studies, the presence and intensity of pain was found to be independent of 
disease duration, age of disease onset, MS type and level of disability.5–10 In contrast, 
other investigators have found significant associations between the presence of pain 
and greater MS-related disability.11–14 Gender differences were demonstrated in three 
studies, with women reporting both increased frequency and intensity of pain.8, 15, 16 
Yet, this finding was not replicated by others.7, 9, 10, 13, 14, 17 Similarly, although the 
prevalence of pain has been found to increase with age in several studies3, 6, 8, 15, 17, 
this finding is not always supported.7, 9, 10, 14 
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General conclusions have been limited by several factors. First, the majority of 
research is based on small, convenience samples presenting to MS specific clinics or 
hospital departments and therefore findings may not generalise to the wider MS 
population. Second, there is no consensus within the literature about the classification 
or definitions of MS-related pain. For example, researchers have adopted different 
time frames for classifying specific types of pain. Further, the arbitrary exclusion of 
various pain conditions (e.g., headaches, optic neuritis) in some studies makes 
comparisons difficult. Third, idiosyncratic methods of pain measurement are common 
and most researchers failed to use standardised pain assessment tools routinely used in 
the pain literature. Most authors devised specific questionnaires, the particular content 
or psychometric properties of which are not routinely reported. Lastly, the level of 
statistical analysis was most often at the univariate or bivariate level. Few researchers 
utilised multivariable modelling to examine complex relationships and to control for 
likely confounding variables.  
 
In summary, MS-related pain is a significant problem which has historically 
been underinvestigated and is currently poorly understood. The vast majority of the 
published literature consists of prevalence studies, descriptive research and clinical 
reports. Where available, empirical data are often limited by methodological and 
analytical problems such that substantive conclusions about the scope and nature of 
MS-related pain remain unclear. To redress these deficiencies and provide a valid and 
detailed assessment of MS-related pain in the community, the following research 
questions were addressed in the present study: 
(1) What is the prevalence and nature of pain experienced by people with MS?  
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(2) What illness and demographic variables are associated with the presence and 
intensity of MS-related pain? 
 
METHODS 
 
Participants 
Postal questionnaires were sent to a community-based sample of people with 
MS (N = 500) recruited from the Multiple Sclerosis Society of Queensland (MSSQ) 
membership database. There is estimated to be approximately 3000 people with MS in 
Queensland, 2139 being registered clients of the MSSQ. Of these, approximately 
1200 people met the eligibility criteria of the study. Systematic random sampling was 
performed such that from a randomized membership roll, every third person was 
selected to a total of 500. Participant eligibility criteria were (1) chronological age 18 
years or older, (2) definite diagnosis of MS confirmed by their neurologist, (3) 
residents of Queensland within two hours drive from Brisbane City, to define a 
geographical area able to be covered by the researcher within the scope of the study, 
(4) fluency of English and therefore able to read and complete the questionnaire 
battery and participate in the pain interview, and (5) able to follow instructions and 
complete the self-report questionnaire correctly, to ensure respondents had adequate 
cognitive functioning. In order to maintain confidentiality, the sampling and 
distribution of questionnaires were undertaken by MSSQ delegates under the 
instructions of the researcher. 
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Procedures 
All participants completed a piloted, self-administered questionnaire booklet 
containing questions about their demographic and clinical characteristics, validated 
measures of quality of life and MS-related disability and a question on whether or not 
they had experienced clinically significant pain in the previous two weeks. It took 
respondents approximately one hour to complete. Each questionnaire was 
accompanied by an introductory letter, study information sheet and a self-addressed 
reply-paid envelope. Request for respondents’ contact details including telephone 
number and home address were included in the questionnaire, along with a single 
question determining whether they would consent to a follow-up interview. To 
increase the response rate, a reminder letter was sent two weeks after the distribution 
of questionnaires.  
 
To identify a subgroup likely to have clinically significant pain, participants 
responded to the following question from the Brief Pain Inventory18 (BPI): 
“Throughout our lives, most of us have had pain from time to time (such as minor 
headaches, sprains, and toothaches). Have you had pain other than these everyday 
types of pain in the last two weeks?” Participants who answered this question 
affirmatively were then contacted and asked to complete an in-person, structured pain 
interview assessing pain characteristics (viz. intensity, quality, location, extent and 
duration), exacerbating and relieving factors, and pain management techniques 
employed. It was decided to administer the pain interviews face-to-face to enhance the 
accuracy of measurement as some instruments were designed to be applied by 
interview (e.g., the McGill Pain Questionnaire19). In addition, this method was chosen 
to prevent missing data and to allow for clarification of responses. 
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 The researcher negotiated, by telephone, a suitable time for the pain interview 
to take place. Most interviews were administered at the respondents’ residences, 
although in four cases the interview took place at another mutually agreed location. 
The pain interview was administered in all cases by the primary researcher (CD) in a 
structured interview format guided by the use of selected instruments. It focused on 
pain experienced in the two weeks preceding the interview in order to limit errors due 
to memory and cognitive impairments. Additionally and in contrast to some past 
investigations3, 10, 15, 17, all types of self reported pain were included (e.g., headache) 
on the grounds that such painful experiences may be related to MS either as a direct 
biological consequence or as a response to the stress of adapting to the disease. A4-
sized show cards were developed for each instrument requiring the choice of multiple 
answers to aid in the accuracy of responses. Average time interval from questionnaire 
to follow-up pain interview was two weeks (range = 1 – 3 weeks). Each interview 
took approximately 45 minutes in duration. The study questionnaire and protocol 
were approved by the Queensland University of Technology Human Research Ethics 
Committee. 
 
Study Measures 
The questionnaire consisted of 18 pages and was divided into three principal 
sections including demographic items, perceived quality of life, clinical characteristics 
and MS-related disability. Only the first and third sections were relevant to the 
purpose of this study and are discussed below. 
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Demographics. Demographic items elicited information about gender, age, 
marital status, highest educational attainment, ethnicity, total annual household 
income, employment status and hours of paid employment per week, and residential 
location. 
 
MS-related measures. The Guy’s Neurological Disability Scale20 (GNDS) is a 
MS-specific measure of disability that evaluates functioning across 12 domains 
including cognition, mood, vision, speech, swallowing, upper limb function, mobility, 
bladder function, bowel function, fatigue, sexual function and other problems. Each 
subscale is graded according to its severity and impact on the individual from 0 
(normal function) to 5 (total loss of function with maximal assistance required), which 
are then summed to give an overall disability score ranging between 0 (no disability) 
and 60 (maximum possible disability). The GNDS has demonstrated high internal 
consistency and test-retest reliability20, 21, and self-report scores have been shown to 
correlate with clinical neurologic examination using the Expanded Disability Status 
Scale (EDSS).22 In the current sample, the internal consistency of the GNDS was 
acceptable (α = .77). Two additional items assessed respondents’ clinical course or 
type of MS, and time since their MS diagnosis. 
 
Pain Measures 
The follow-up pain interview included several standardised pain measures 
described below.  
 
Pain intensity. 11-point numerical rating scales (NRS-11; 0 = no pain, 10 = 
pain as bad as it could be) from the BPI were used to assess pain intensity levels at 
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present, worst, least and on average over the previous two weeks. Each participant 
was read standardised instructions for the NRS-11 developed by Wilkie23. The 
reliability and validity of numerical rating scales of pain intensity is well 
documented.24, 25  
 
Pain quality. The McGill Pain Questionnaire26 (MPQ) measures the sensory, 
affective and evaluative aspects of the pain experience, based on the gate-control 
theory. The psychometric properties of the MPQ have been well established27, 28 and 
the MPQ is often utilised as a ‘gold standard’ against which to validate pain measures. 
It consists of 78 pain descriptors which are categorised into 20 groups evaluating the 
major dimensions of pain quality. Participants were read each list of descriptors and 
could select one word from each group if applicable to their pain. In order to prevent 
measurement error due to MS-related memory or recall problems, A4-sized show 
cards were created for each group of words. Each of the 78 words are assigned a rank 
value within its group and from these data it is possible to derive a pain rating index 
(PRI) for the sensory, affective, evaluative and miscellaneous subscales, as well as a 
total PRI.26  
 
Pain location and extent. In order to measure the sensory distribution of pain, 
participants also completed a pain drawing which comprised outlines of the human 
body, front and back, on which to shade in their pain site(s). The pain drawing was 
enlarged (16cm tall) to fit a single A4 page. Margolis and colleagues29, 30 have 
developed a scoring system where the drawing is divided into 45 areas, each with a 
corresponding percentage value in order to compute the total body area percentage in 
pain. This technique was applied using a clear plastic template to score percentage 
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values. The test-retest and inter-rater reliability of data from these pain drawings have 
been established.29, 30   
 
Other pain-related variables. Along with other components of the pain 
interview, data was collected from each participant about the time since onset of MS-
related pain, exacerbating and relieving pain factors, and current pain management 
techniques employed. Data were transcribed verbatim in list format and later divided 
into conceptual categories for analysis.    
 
Statistical Analyses 
Data analysis was undertaken by means of the Statistical Package for the 
Social Sciences (SPSS, Chicago, USA). There was generally minimal missing data 
(<5% at the item level) across all measures, except for items concerning sexual 
activity in the GNDS where it reached 12%. Exploration of the pattern of missing data 
revealed that respondents and nonrespondents did not differ in terms of background 
characteristics. Since the extent of missing data was not extensive, sample mean 
substitution was utilized for subsequent analyses. 
 
Descriptive statistics (means, standard deviations, ranges, frequency counts, 
percentages) were calculated to profile sample characteristics and to determine pain 
prevalence and characteristics. At the bivariate level, contingency chi-square tests, 
independent t-tests and Pearson product-moment correlations were used to evaluate 
the associations among illness and demographic variables and pain measures. 
Stepwise multiple logistic regression and multiple linear regression analyses were 
then undertaken to determine the most parsimonious set of variables that predicted the 
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presence/absence of pain and pain intensity respectively. For all analyses an alpha 
level of < .05 (two-tailed) was considered statistically significant.  
 
RESULTS 
 
Response Rate 
Of the 500 postal questionnaires, 30 were returned due to incorrect addresses, 
7 addressees were deceased and a further 7 reported that they did not meet the 
eligibility criteria. Therefore, of the possible 456 questionnaires distributed, 219 were 
returned giving an overall response rate of 48%. Information on nonrespondents was 
not available since the researcher, in order to maintain participant confidentiality, did 
not have access to the mailing list. 
 
Sample Characteristics 
The demographic characteristics of the sample are summarised in Table 1. 
With a mean age of 51.1 years (SD = 12.0, range = 24 – 82), respondents were 
predominantly Anglo-Australian women who were married, well-educated and living 
in an urban area. Approximately two-thirds of the sample indicated that they were not 
in paid employment at the time of the investigation. Participants who were employed 
reported a median of 25 hours of work per week (range = 3 – 55). Almost half of the 
sample (46.6%) reported an annual household income of up to AUD$25K per annum, 
which approximates the second lowest quintile of household income in Australia.31 
 
Table 2 presents the clinical characteristics of the sample. The median time 
since MS diagnosis was 9 years (range = 0.5 – 60.0 years). Approximately half of the 
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sample described a relapsing-remitting disease course. Respondents’ GNDS scores 
reflected a range of severity of MS-related disability within the sample, with an 
overall mean score of 18.5 (SD = 9.4, range = 0 – 48). The mean number of MS-
related symptoms reported on the GNDS was 7.2 (SD = 2.7, range = 0 – 12) with 
respondents being most affected by fatigue, bladder dysfunction, mobility and sexual 
problems. Speech, swallowing and visual disability, in comparison, were reported to 
be relatively minor. In the last subscale (i.e., ‘other problems’), 62.1% of the sample 
identified a problem not previously addressed by the scale. Of these, the most frequent 
was spasticity (39%), followed by sensory symptoms (i.e., numbness, paresthesias) 
(33%) and dizziness and vertigo (28%).  
 
What is the Prevalence and Nature of Pain Experienced by People with MS?  
Of the 219 respondents, 147 reported clinically significant pain during the two 
weeks preceding the study yielding a point prevalence of 67.1% (95% CI = 60.9% to 
73.3%). Of those reporting pain, complete pain interview data were available for 105 
respondents. Reasons for respondents not being administered the pain interview 
included: no or incorrect contact details given (2); respondents now lived greater than 
two hours drive from Brisbane Central Business District (3); respondents were 
unavailable or not able to be contacted (20); or they did not consent to the pain 
interview (as indicated on the questionnaire, 17). The following descriptive data are 
based on this sub-sample of 105 respondents reporting a current pain problem. When 
compared across background characteristics, participants who completed the pain 
interview were similar to those lost to follow-up except for age, with respondents 
slightly older (mean ± SD, 52.3 years ± 11.3) compared to nonrespondents (mean, 
48.1 years ± 11.4), t(139) = 2.1, p = 0.037. 
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 Participants reported a mean pain intensity ‘on average’ of 4.6 (SD = 2.1, 
range = 0 – 10) for the two weeks preceding the interview. Mean scores of pain ‘right 
now’ and ‘pain at its least’ were reported as 3.1 (SD = 2.5, range = 0 – 10) and 1.8 
(SD = 2.0, range = 0 – 8), respectively. Mean pain intensity ‘at its worst’ was 7.4 (SD 
= 2.1, range = 2 – 10). Table 3 shows the distribution of pain intensity scores when 
grouped by cutpoints representing mild (1 – 4), moderate (5 – 6) and severe (7 – 10) 
pain, following the work of Serlin et al.32. Notably, although 41.9% of participants 
rated their average pain intensity as mild, the majority reported a typical background 
pain of moderate (37.1%) to severe (18.1%) intensity. Approximately two-thirds of 
the sample reported their pain intensity ‘at its worst’ to be in the severe range. 
 
The descriptive data derived from the MPQ are shown in Table 4. MS-related 
pain was predominately sensory-discriminative in quality, the most frequently 
endorsed descriptors (chosen by > 33% of respondents) being sharp (54.3%), shooting 
(49.5%), cramping (45.7%), burning (43.8%), aching (42.9%), throbbing (39%) and 
tingling (38.1%). Affective and evaluative descriptors most frequently chosen were 
exhausting (59.0%), annoying (45.7%) and nagging (53.3%). In addition to these 
descriptors, study participants often supplemented the MPQ with analogies or 
metaphors to describe the quality of their pain. Common examples reported by 
participants included feeling as if they had ‘severe sunburn under a cold shower’, or 
as if their ‘legs were on fire’.  
 
In terms of the 45 anatomical areas defined by the scoring template of the 
Margolis pain drawing, the median number of painful locations reported by the 
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sample was 10 (range = 1 – 43). The median percentage of body surface area in pain 
reported by the sample was 26.5% (range = 4.0 – 96.5%). Pain locations were also 
scored according to a broader categorization of body regions similar to classifications 
used by others in the MS-related pain literature5 (see Table 5). Based on this 
classification, three-quarters of the sample reported pain in 3 or more locations, with 
respondents reporting an average of 4.0 (SD = 1.8) distinct pain sites. Total number of 
pain sites were found to be significantly associated with overall MS-related disability 
score (r = .28, p = .006). Although the median duration of pain for the sample was 6.0 
years (range = 1 month – 36 years), for a substantial minority (34.3%) pain had 
persisted for over 10 years. The majority of participants (68.0%) reported that they 
experienced pain on a constant, daily basis and most of the remainder (24.5%) 
described their pain as intermittent.   
 
Respondents were also able to identify a number of factors known to provoke 
or exacerbate their pain. Table 6 reports the percentage of respondents reporting each 
factor. Participants most commonly stated that prolonged activity or overexertion 
made their pain worse. Changes in environmental temperature, bodily 
posture/position, stress, fatigue and sensory stimulation were also reported to 
exacerbate pain. The data on pain management techniques utilised by the sample are 
summarised in Table 7. The mean number of pain management techniques reported 
by participants was 3.3 (SD = 1.7, range = 0 – 8). When compared by background 
characteristics, women reported more pain management techniques than men (mean, 
3.5 ± 1.6 vs. 2.4 ± 2.1; t(103) = 2.4, p = .017), as did participants in paid employment 
compared with those not in current paid employment (mean, 4.1 ± 1.8 vs. 2.9 ± 1.6; 
t(103) = 3.3, p = .001). Number of reported techniques did not significantly differ by 
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other characteristics. Most participants (83.8%) took medications regularly for pain 
relief, although these were predominately over-the-counter, simple analgesics such as 
nonopioids and nonsteroidal anti-inflammatory drugs (NSAIDs). Participants 
employed a range of other nondrug pain management techniques including 
physical/exercise therapy, thermotherapy, rest/sleep, distraction, relaxation 
techniques, as well as a range of alternative and complementary therapies. 
 
What Illness and Demographic Variables are Associated with the Presence and 
Intensity of MS-related Pain? 
In order to determine whether pain prevalence differed by illness and 
demographic characteristics, comparisons between participants with and without MS-
related pain were first conducted at the bivariate level. Location was omitted given the 
low cell count in suburban and rural categories. These analyses did not reveal any 
significant associations between the presence of pain and age, marital status, 
educational level, ethnicity, socioeconomic or employment status (see Table 8). In 
addition, although there was a notably higher proportion of women (69.3%) reporting 
pain compared to men (57.5%), this difference fell short of statistical significance (χ² 
= 1.6, p = .21). In terms of illness-related variables, no significant differences existed 
between the two groups with regard to disease course or time since MS diagnosis. 
However, the presence of pain was associated with more severe MS-related disability 
with a mean difference of 6.0 score units on the GNDS (95% CI = 3.5 to 8.4), t(217) = 
−4.8, p < .001. When pain prevalence was considered by GNDS class intervals, the 
report of pain became more common with increasing level of disability (see Figure 1), 
χ² = 27.0, p < .001. 
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A stepwise multiple logistic regression was subsequently conducted to 
examine the independent associations of illness and demographic characteristics with 
the presence of clinically significant pain. All demographic variables were entered, 
along with time since diagnosis and MS type. In addition, as MS-related disability 
was significant at the bivariate level, all 12 GNDS scales were entered to identify 
important associations with specific disability scales. As shown in Table 9, the final 
model fit the data well (Hosmer-Lemeshow goodness-of-fit test, χ² = 4.86, p = .77). 
When considered together, four of the background variables were significantly related 
to the likelihood of having clinically significant pain, namely gender, cognition, 
sexual function and ‘other problems’ (as indicated on the GNDS, e.g., spasms, 
vertigo, paresthesias). Being female increased participants’ likelihood of experiencing 
MS-related pain more than threefold relative to males (odds ratio = 3.40; Wald = 6.69, 
p = .01). In addition, each unit change on the cognition (Wald = 4.25, p = .039), 
sexual function (Wald = 8.61, p = .003) and other (Wald = 20.07, p < .001) scales of 
the GNDS increased participants’ likelihood of pain 1.4, 1.3 and 1.9 times, 
respectively.  
 
In order to examine associations between illness and demographic 
characteristics and pain intensity among respondents reporting a current pain problem, 
a stepwise multiple linear regression analysis was employed. All illness-related and 
demographic variables were entered as independent variables, with pain intensity as 
measured by the MPQ PRI-total as the dependent variable. As shown in Table 10, the 
final model which accounted for 27% of the variation included disability, gender, 
marital status and time since diagnosis. Greater severity of MS-related disability (t = 
4.31, p < .001) and female gender (t = 2.47, p = .015) were significantly associated 
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with higher levels of pain intensity, whereas being in a married/defacto relationship (t 
= −2.28, p = .025) and longer time since MS diagnosis (t = −2.24, p = .028) were 
correlated with lower pain ratings. 
 
DISCUSSION 
 
In this large, community-based sample of people with MS, clinically 
significant pain was experienced by 67.1% of participants during the two weeks 
preceding the survey. This finding is consistent with a growing consensus in the 
literature that pain is experienced by approximately two-thirds of the MS population 
over the course of their illness5–8, 17 and reaffirms that pain is a significant problem 
among people with MS. Others have found considerably lower3, 11, 13, 14, or higher4, 12, 
33, prevalence rates which likely reflect differences in sampling procedures, 
measurement and classification systems used, or timeframes and exclusion criteria for 
MS-related pain.  
 
Indeed, several inconsistencies and methodological limitations within the 
extant MS-related pain literature have generally precluded substantive conclusions 
about the prevalence and nature of pain experienced. Notably, almost all available 
data is based on convenience samples drawn from specialised clinics or hospital 
departments, thereby limiting the generalisability of findings. This study therefore 
sought to overcome many of these limitations by employing (1) community-based, 
systematic random sampling; (2) comprehensive, in-person structured pain interviews; 
(3) the use of standardised pain measures; and (4) the inclusion of all self-reported 
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pain problems within two weeks preceding the survey, so as to include clinically 
meaningful pain while avoiding information bias due to memory problems.         
 
Although the current study attempted to correct a number of methodological 
limitations of previous prevalence studies, the findings may have been influenced by a 
number of factors. Despite efforts to emphasize study participation regardless of pain 
status, the results may reflect some degree of selection bias. That is, respondents with 
pain may have been more or less likely to complete the questionnaire than those 
without and therefore be over- or under-represented in this sample. Moreover, because 
the sample was restricted to members of the Queensland MS Society, the sample may 
have been biased toward persons with differing characteristics, such as individuals 
with greater access to resources. Nonetheless, the background characteristics of the 
sample were quite representative of the target population and other published 
epidemiological data.   
 
The high prevalence of pain experienced in the MS population raises the 
question of why some individuals do not develop pain over the course of the disease. 
It could prove informative to determine what demographic, clinical and psychosocial 
factors protect against the development of chronic pain problems. Compatible with 
previous studies, the current study found the presence of MS-related pain to be 
unrelated to several important demographic and clinical variables including age, 
marital status, educational level, ethnicity, socio-economic and employment status, 
disease course or time since diagnosis. Pain was however, significantly correlated 
with level of disability, as measured by the GNDS. This suggests that pain may be 
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more likely amongst those with greater disease severity, although this relationship 
remains unclear from these cross-sectional results.  
 
When considered independently by logistic regression, cognition, sexual 
function and ‘other’ scales of the GNDS were found to be significantly associated 
with the presence of pain. It may be that individuals with greater cognitive 
impairment are more likely to experience ongoing pain due to impaired cognitive 
coping and problem solving abilities. On the other hand, both cognitive34, 35 and 
sexual36, 37 difficulties are common among persons with chronic pain as a primary 
condition. MS-related pain may itself create memory and concentration difficulties 
and interfere with sexual interest and functioning. Further investigation is needed to 
determine the nature of these relationships. The only study to examine the relationship 
between pain and cognitive functioning in MS found no differences in performance 
on a task of auditory verbal learning between those with and without pain.17 The 
finding that the ‘other’ GNDS variable was significantly associated with pain must be 
qualified by the fact that it commonly included potentially painful conditions such as 
spasms and paresthesias. Hence, this finding may simply indicate that as participants 
developed more MS-related symptoms that may be painful, they are more likely to 
develop pain.  
 
Few consistent findings about clinical characteristics associated with pain have 
emerged from previous research. Several studies failed to identify any relationship 
between MS-related pain and indices of disease progression, such as disease course, 
duration or severity.5–10 In contrast, Brochet et al.11 prospectively assessed 108 people 
with MS over a 3 year period and found that pain occurred more frequently during 
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acute relapses and pain persisted more frequently when exacerbations were followed 
by residual neurological deficit. These authors reported a significant correlation 
between pain and increased disability, as measured by the Kurtzke Disability Status 
Scale (DSS). Stenager et al.12 also demonstrated that over a five year period, 
participants with deteriorating DSS scores were significantly more likely to 
experience pain. Recent large, cross-sectional studies by Ehde et al.13 and Solaro et 
al.14 also found pain prevalence increased with greater disease severity, as defined by 
the EDSS.  
 
Here, logistic regression also revealed that being female independently 
increased participants’ probability of experiencing MS-related pain more than 
threefold (OR = 3.40, 95% CI = 1.4 to 8.6). This finding is compatible with previous 
studies8, 15, 16 demonstrating women were significantly more likely to report MS-
related pain than men. It is also consistent with increasing evidence that several 
chronic pain problems appear to have a specific gender distribution. Women appear to 
be at greater risk of a variety of recurrent and chronic pain conditions such as 
headache, facial pain, abdominal pain and musculoskeletal pain.38, 39 Both biological 
and psychosocial factors have been hypothesised to account for these findings, such as 
gender differences in social role expectancies, cognitive appraisals, coping strategies, 
familial factors, anatomical structures, hormones and brain chemistry.38, 40 It should be 
noted however, that the current sample predominately included women, yielding a 
female to male ratio of approximately 4:1, which does not correspond with the 2−3:1 
gender ratio typical of the MS population.41 
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An important finding in this study was that pain in people with MS is not only 
common, but it is also usually chronic and often severe in nature. At the time of 
investigation the median duration of pain was 6 years, but for a significant minority 
(34.3%), pain had existed for over 10 years. Of those participants with pain, 68% 
reported that they experienced pain on a constant, daily basis. Most of the remainder 
(24.5%) also experienced pain on a daily basis, although it was described as 
intermittent. Thus, once MS-related pain develops, it is usually a chronic, persistent 
problem over the course of the illness.  
 
Participants reported a mean pain intensity ‘on average’ of 4.6 (SD = 2.1; on a 
0–10 scale) for the two weeks preceding the interview, which is similar to that 
reported by other authors. Four studies found average pain intensity among people 
with MS to range from 4.6 to 5.8 utilising the numerical rating scale.4, 8, 9, 13 Further 
examination of the data however, reveals that over half (55.2%) of the current sample 
reported a typical background pain of moderate-to-severe intensity (≥ 5 on a 0 – 10 
scale). In addition, approximately two-thirds (67.6%) of the sample reported their pain 
intensity ‘at its worst’ over the preceding fortnight to be in the severe range. These 
findings replicate those of Ehde et al.13, who reported average pain intensity was often 
moderate (35.6%) to severe (26.7%) for their community-based MS sample over the 
three months preceding their survey, as measured by the NRS-11. 
 
Findings from the MPQ further demonstrate that the severity of MS-related 
pain is considerable. The mean total pain rating index (PRI-total) for the sample was 
30.67 (SD = 11.43), exceeding calculated normative PRI-total mean scores reported 
by Wilkie et al.27 for chronic cancer (24.0), low back (27.9) and mixed (25.4) pain 
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conditions. Participants’ mean scores were also appreciably higher when compared to 
means reported for Australian samples of chronic rheumatoid arthritis42, orofacial 
pain43 and chronic post-surgical pain44.  
 
The qualitative aspects of pain reported by this sample are similar to those 
found in the MS literature.6, 8, 45 Interestingly, participants scored comparatively lower 
on the affective and evaluative dimensions of the MPQ. One possible explanation for 
this finding is that pain is less distressing or threatening to individuals in the context 
of other intrusive MS-related symptoms. Or, as is suggested by previous qualitative 
findings46, individuals may come to accept pain as a permanent consequence of 
disability, one that becomes an enduring part of daily life. Thus they might tend to 
perceive and discuss pain primarily in terms of its sensory qualities rather than its 
affective-evaluative dimensions.        
 
Descriptive findings from the MPQ were also remarkably similar to those of 
Dudgeon et al.47 who explored the qualitative features of disability-related pain 
among people with lower-limb amputations, spinal cord injury and cerebral palsy, 
using both the MPQ and open-ended pain interviews. The authors found word pattern 
use to be similar across groups and therefore suggested a set of 15 adjectives, derived 
from the most frequent descriptors, to inform disability-related pain assessment. 
These adjectives correspond well with the current findings and may have clinical 
utility in the MS population.  
 
Like Dudgeon et al.47 however, we also found that during pain interviews 
study participants often supplemented the MPQ with analogies or metaphors to 
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describe the quality of their pain. Some participants described a sensation similar to 
‘severe sunburn under a cold shower’, or as if their ‘legs were on fire’, or explained 
their ‘whole body ached with fatigue’. Such descriptions likely represent the often 
frustrated attempts of individuals with central pain to convey their subjective 
experience48 and perhaps point to a limitation of measures such as the MPQ to 
adequately assess the complex nature of chronic disability-related pain.47    
 
Little is known about what factors influence pain intensity among people with 
MS. A correlational study by Brunet et al.49 found higher income and relapsing-
remitting MS predicted lower pain levels, while a family history of MS and the 
presence of headaches were associated with higher pain severity, as measured by the 
SF-36 Bodily Pain (BP) Scale. Other investigators however, have found no 
association between pain severity and age, disease duration, MS subtype or EDSS 
scores.4, 7, 9, 50      
 
In the current study, regression analysis revealed that women and participants 
with greater disease severity reported significantly higher levels of pain, whereas 
being in a married/defacto relationship and longer time since diagnosis predicted 
lower pain scores on the MPQ. The finding that women reported greater pain severity 
is consistent with three previous studies in the MS literature8, 16, 50, as well as evidence 
from other pain-related conditions such as rheumatoid/osteoarthritis51, 52, HIV/AIDS53 
and neuromuscular disease54, suggesting that women who have chronically painful 
conditions are likely to report heightened pain compared to men. Overall MS-related 
disability score demonstrated the strongest association with pain intensity, which 
stands in contrast to previous findings.7, 9, 50 However, since several pain variables in 
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this study were correlated with disease severity, the conclusion that pain is related to 
advanced disease seems warranted. Being in a partnered relationship was associated 
with significantly lower pain intensity, suggesting that social support may be an 
important buffer against the development of severe pain problems.55, 56 Longer time 
since MS diagnosis also predicted lower pain intensity which may reflect increased 
attempts to employ self-management strategies and greater adaptation to illness over 
time.57 Taken together, these findings suggest that in contrast to a biomedical model 
of disability-related pain that ties pain severity solely to disease activity and 
impairment, a range of factors likely interact to influence the severity of MS-related 
pain.  
 
It is noteworthy that the majority of study participants reported multiple pain 
locations, experiencing several types of pain simultaneously. When scored across nine 
bodily regions, participants reported a mean of 4.0 (SD = 1.8) different pain sites. 
Three-quarters of the sample reported pain in 3 or more locations.  Participants most 
commonly described pain in the lower extremities, although pain was frequently 
reported in the back, neck, upper extremities and facial regions also. The number of 
painful regions and localization of pain as found in this study are very similar to those 
found by others.6, 8, 14 Archibald et al.9 found that 89% of subjects with MS-related 
pain had multiple anatomically separate pain sites, reporting a mean of 4.1 pain 
locations. The present data also show that number of pain locations was positively 
correlated with MS-related disability. Although previous studies have failed to 
examine this relationship, a compounded effect of multiple areas of pain on 
functioning seems likely. Thus, it may be important to consider more than simply the 
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presence or severity of pain when examining the relationship between pain and MS-
related disability.   
 
Moreover, given that individuals with MS typically experience multiple pain 
problems, additional studies are needed to determine the causes of these conditions 
and whether there are common patterns of multiple pain problems in this population. 
The pain variables assessed in the current study focused on the overall subjective 
experience of MS-related pain. However, given the diverse nature of MS-related pain, 
it may be useful for future research to clinically differentiate between pain conditions 
and perform detailed analyses by pain type, since each may have varying intensity and 
functional consequences.58  
 
Participants were able to identify a number of factors that were known to 
provoke or exacerbate their pain. The most common triggers were prolonged activity 
or overexertion, changes in environmental temperatures or bodily posture/position. 
Others noted that stress, fatigue and sensory stimulation aggravated pain. In addition, 
participants reported a variety of treatments and strategies they employed to alleviate 
pain. Most participants (83.8%) took medications regularly for pain, although these 
were predominantly non-prescription, simple analgesics such as nonopioids (e.g., 
paracetamol and aspirin products) and NSAIDs (e.g., ibuprofen). Although 
anecdotally ineffectual, most study participants self-medicated with simple analgesic 
preparations and therefore health care providers should be aware of the extent of over-
the-counter medication use when new drug therapies are initiated. Approximately less 
than one-fifth of participants who reported pain were being treated with opioid or 
adjuvant pharmacotherapy.  
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 Several non-pharmacologic pain management strategies, including physical 
therapy, thermotherapy, rest/sleep, distraction, relaxation techniques and alternative 
therapies were also utilised by participants. It is unknown whether these strategies 
were initiated by study participants or whether health care professionals 
recommended them. However, given the number and diversity of therapies 
spontaneously reported, future research should examine the effectiveness and 
comparative effectiveness of these strategies so that clinicians can base 
recommendation and treatment on empirical evidence.  
 
Study participants reported an average of 3.3 (SD = 1.7) current pain 
management techniques, with greater numbers of techniques being reported by 
women and those in paid employment. Heckman-Stone and Stone4 similarly found 
women with MS reported more pain management strategies than men, citing higher 
health care use among women and a greater willingness to try nonmedication 
strategies as potential explanations. Women may also be more motivated to try pain-
relieving techniques since they reported greater pain intensity. Similarly, individuals 
may attempt to cope with MS-related pain by using a variety of self-management 
strategies to remain employed. Further inquiry into the effectiveness of pain 
management techniques used by people with MS in the community and potential 
barriers to self-management should be the target of future research.  
 
CONCLUSIONS 
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Consistent with previous research, pain was found to be common among 
people with MS, with approximately two-thirds (67.1%) of this community-based 
sample reporting pain during the two weeks preceding the study. Comprehensive pain 
assessment revealed that a substantial subset of these individuals experience chronic 
pain conditions characterised by moderate-to-severe pain intensity. Moreover, study 
participants reported an average of 4 concurrent pain sites. These findings underscore 
the need for increased clinical focus on assessment and management of MS-related 
pain.  
 
In contrast to previous cross-sectional studies, greater severity of  MS-related 
disability was found to be strongly correlated with both pain prevalence and severity. 
Greater disability was also associated with multiple pain locations. Taken together, 
these results suggest that individuals with more severe MS are at a greater risk for 
developing clinically significant pain. This explanation seems biologically plausible, 
yet one that remains confounded by the correlational research design. Longitudinal 
research is required that examines how MS-related disability and pain covary over 
time.    
 
The findings also demonstrate significant gender differences as women were 
independently associated with both increased prevalence and severity of MS-related 
pain. Women also reported greater extent of pain compared to men and employed a 
greater number of self-management strategies. Thus, women with MS may be at 
particular risk for developing pain problems. Previous research has not examined 
gender differences in MS-related pain in any depth beyond prevalence studies. Future 
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research should seek to clarify the mechanisms that underlie these observations and 
consider gender differences in design and data analysis.     
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TABLES 
 
Table 1. Demographic characteristics of the sample (N = 219) 
Characteristic n % 
Gender   
Female  179 81.7 
Male 40 18.3 
Marital status*   
Single 46 21.2 
Married/defacto 136 62.7 
Separated/widowed 35 16.1 
Educational level†   
Less than high school graduate 22 10.1 
High school graduate 108 49.5 
Apprenticeship 18 8.3 
University or college 53 24.3 
Postgraduate 17 7.8 
Ethnicity   
Anglo-Australian 205 93.6 
European 9 4.1 
Other 5 2.3 
Annual household income (AUD$)‡   
<$10,000 26 13.5 
$10,000 to 24,999 64 33.1 
$25,000 to 49,999 55 28.5 
>$50,000 48 24.9 
Employment status*   
Paid employment 73 33.6 
Not in paid employment  144 66.4 
Location§   
Urban 191 88.4 
Suburban 15 6.9 
Rural 10 4.6 
*2 missing data, †1 missing data, ‡26 missing data, §3 missing data. 
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Table 2. Clinical characteristics of the sample (N = 219) 
Characteristic   
Disease course n % 
Relapsing-remitting 106 48.4 
Secondary-progressive 36 16.4 
Primary-progressive 46 21.0 
Other 31 14.2 
GNDS scale M SD 
Cognition 1.3 1.1 
Mood 1.3 1.3 
Vision 0.8 0.7 
Speech 0.5 0.9 
Swallowing 0.6 1.1 
Upper limb function 1.5 1.4 
Lower limb function 2.2 1.7 
Bladder function 2.5 1.8 
Bowel function 1.3 1.5 
Fatigue 2.7 1.6 
Sexual function* 2.0 2.1 
Other  1.8 1.7 
Abbreviation: GNDS, Guy’s Neurological Disability Scale. 
*26 missing data.  
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Table 3. Distribution of pain intensity scores (n = 105) 
 Mild 
(NRS 1 – 4)
Moderate 
(NRS 5 – 6)
Severe 
(NRS 7 – 10) 
Present pain 46.7 21.0 10.5 
Worst pain 10.5 21.9 67.6 
Least pain 46.7 10.5 1.9 
Average pain 41.9 37.1 18.1 
NOTE. Values expressed as percentages. Percentages add up to <100 where  
participants could give ratings of 0.      
Abbreviation: NRS, Numerical pain rating scale. 
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Table 4. McGill Pain Questionnaire scores for people with MS (n = 105) 
Variable M SD 
Possible 
Range 
Actual 
Range 
PRI–Total  30.67 11.43 0 – 78 6 – 64 
PRI–Sensory 19.10 6.96 0 – 42 4 – 35 
PRI–Affective  4.14 2.98 0 – 14 0 – 11 
PRI–Evaluative  2.26 1.43 0 – 5 0 – 5 
PRI–Miscellaneous  5.17 3.10 0 – 17 0 – 14 
Number of Words Chosen 12.74 3.96 0 – 20 4 – 20 
Abbreviation: PRI, Pain rating index. 
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Table 5. Pain locations reported by people with MS (n = 105) 
Location Frequency % 
Head 23 21.9 
Back 71 67.6 
Neck 40 38.1 
Face 36 34.3 
Arms 35 33.3 
Hands 39 37.1 
Trunk 26 24.8 
Legs 90 85.7 
Feet 57 54.3 
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Table 6. Factors reported to exacerbate MS-related pain (n = 105) 
 Frequency % 
Activity/exercise 49 46.7 
Environmental temperature 37 35.2 
Postural 
(e.g., immobility, certain movements) 
33 31.4 
Stress 26 24.8 
Fatigue 20 19.0 
Sensory stimulation 
(e.g., light touch, friction)  
9 8.6 
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Table 7. Pain management techniques used for MS-related pain (n = 105) 
 Frequency % 
Medications   
Nonopioid analgesics 65 61.9 
Anti-inflammatories 30 28.6 
Spasmolytics 22 21.0 
Antidepressants 19 18.1 
Opioids 15 14.3 
Anticonvulsants 11 10.5 
Alternative medicines 9 8.6 
Disease modifying agents 8 7.6 
Other treatments   
Physical/exercise therapy 
(e.g., massage, physiotherapy) 
55 52.4 
Thermotherapy 
(e.g., hot or cold) 
36 34.3 
Rest/sleep 29 27.6 
Distraction 
(e.g., work, recreation) 
21 20.0 
Relaxation techniques 
(e.g., meditation, guided imagery) 
16 15.2 
Alternative therapies 
(e.g., acupuncture, aromatherapy, 
 hypnosis, magnetic therapy) 
13 12.4 
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Table 8. Comparison of participants with and without MS-related pain (N = 219) 
 With Pain
(n = 147) 
Without Pain
(n = 72) 
  
Variable n (%) n (%) χ² / t p* 
Gender     
Male 23 (57.5) 17 (42.5)   
Female 124 (69.3) 55 (30.7) 1.6 .21 
Marital Status     
Single 28 (60.9) 18 (39.1)   
Married/defacto 96 (70.6) 40 (29.4)   
Separated/widowed 21 (60.0) 14 (40.0) 2.3 .31 
Educational Level     
Less than high school graduate 14 (63.6) 8 (36.4)   
High school graduate 76 (70.4) 32 (29.6)   
Apprenticeship 12 (66.7) 6 (33.3)   
University or college 35 (66.0) 18 (34.0)   
Postgraduate 9 (52.9) 8 (47.1) 2.2 .70 
Ethnicity     
Anglo-Australian 138 (67.3) 67 (32.7)   
Other 8 (61.5) 5 (38.5) 0.0 .90 
Annual Household Income      
<$10,000 16 (61.5) 10 (38.5)   
$10,000 to 24,999 49 (76.6) 15 (23.4)   
$25,000 to 49,999 37 (67.3) 18 (32.7)   
>$50,000 28 (58.3) 20 (41.7) 4.6 .20 
Employment Status     
Paid employment 46 (63.0) 27 (37.0)   
Not in paid employment 99 (68.8) 45 (31.2) 0.5 .49 
MS Type     
Relapsing-remitting 76 (71.7) 30 (28.3)   
Secondary-progressive 31 (86.1) 5 (13.9)   
Primary-progressive 38 (82.6) 8 (17.4) 4.2 .12 
Age     
mean (SD) 51.3 (11.5) 50.6 (13.2) 0.4 .69 
Time Since MS Diagnosis     
mean (SD) 11.2 (9.7) 12.4 (10.3) –0.9 .38 
Disability (GNDS)     
mean (SD) 20.4 (8.7) 14.4 (8.5) 4.8 < .001 
*p values calculated using chi-square tests except for age, time since diagnosis and disability for which 
independent t-tests were used. 
 
 42
Table 9. Logistic regression predicting the presence of pain from demographic 
and clinical characteristics in people with MS (N = 219) 
Variable Wald 
Odds 
Ratio* 95% CI p 
Female 6.69 3.40 (1.35, 8.58) .01 
GNDS cognition scale 4.25 1.40 (1.02, 1.94) .039 
GNDS sexual function scale† 8.61 1.34 (1.10, 1.63) .003 
GNDS ‘other’ scale 20.07 1.85 (1.41, 2.42) < .001 
Constant 12.89   < .001 
Overall Model     
−2 Log Likelihood 177.82    
Model Chi-square (df = 3) 49.12    
p  < .001    
Abbreviation: GNDS, Guy’s Neurological Disability Scale.  
*Odds ratios mutually adjusted for all other variables, †Sample mean substitution for missing data. 
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Table 10. Stepwise multiple regression predicting pain intensity from illness and 
demographic variables in people with MS (n = 105) 
Predictor Variables b SE b  β sr² 
Disability (GNDS) 0.47 0.11  .40† .16 
Female 6.71 2.71 .23* .05 
Married/defacto −5.08 2.23 −.21* .04 
Time since diagnosis –0.23 0.10 −.21* .04 
Constant 20.13†    
Overall Model     
F(4, 100) = 8.0, p < .001     
R² = .27     
 *p < .05, †p < .001 
 
 
 
